Peptide Based Gastrointestinal Disorders Therapeutics Market Expectations & Growth Trends Highlighted until 2022 | Key Players - Shire plc, Ironwood Pharmaceuticals, Astellas Pharma , Allergan plc, Accredo Health Group
Get Sample PDF Copy @ https://www.factmr.com/connectus/sample?flag=S&rep_id=190
Growing occurrence of metabolic disorders and gastrointestinal ailments related to the digestive system is compelling physicians to utilize novel therapeutic drugs that are more efficient than the traditional ones. In addition, incessant structural improvements in peptide synthesis coupled with development of high-throughput approaches and hybrid mixing of solid and liquid synthesis is partly responsible for the exciting preclinical results shown by new peptide drugs for treating a number of gastrointestinal diseases. Drug makers are also emphasising on enhancing peptide properties, such as stability and half-life to overcome few of the limitations of peptides. In recent years, a lot of progress has been made in developing efficacious peptide therapeutics. Nonetheless, the high complexity of peptides remain a major challenge for manufacturers and hence dampening the surging spirit of the market to a certain extent.
Highlights of the Report Include:
North America currently commands for the largest share of the global market in terms of revenue and the trend is likely to continue over the next five years. The region’s market is expected to expand at little under 14% CAGR over the forecast period. This growth is attributed to the rising adoption of peptide based drugs and increasing patient awareness about new and novel therapeutic treatments.
Based on drugs, global sales of linaclotide for treatment of gastrointestinal ailments is significantly high. Sales of linaclotide currently commands for over two-third revenue share of the global market. By the end of 2022, over US$ 466 Mn worth linaclotide peptide drugs are estimated to be sold across the globe.
Browse More Information about this Report @ https://www.factmr.com/report/190/peptide-based-gastrointestinal-disorders-therapeutics-market
Hospital pharmacies is expected to remain the most attractive distribution channel for peptide based gastrointestinal disorders therapeutic drugs throughout the assessment period. In terms of revenue, hospital pharmacies currently account for nearly 50% share of the global market and the figure is unlikely observer any major alteration over 2022. Meanwhile, retail pharmacies will continue to hold the second position and reflect an impressive growth during the five years of forecast.
Some of the leading companies operating in the global market for peptide based gastrointestinal disorders therapeutics include Ironwood Pharmaceuticals, Inc., Allergan plc, Shire plc, Astellas Pharma Inc., and Accredo Health Group, Inc. A majority of these market players are concentrating on development of new peptide drugs in order to expand their product portfolio. Hence, increasing emphasis on improving the efficacies of peptide drugs is likely to reflect favourably on the sales of peptide based therapeutic drugs for treating gastrointestinal disorders.
Make an Enquiry before buying this report @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=190
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
11140 Rockville Pike
Rockville, MD 20852
Read Industry News at - https://www.industrynewsanalysis.com/
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Based Gastrointestinal Disorders Therapeutics Market Expectations & Growth Trends Highlighted until 2022 | Key Players - Shire plc, Ironwood Pharmaceuticals, Astellas Pharma , Allergan plc, Accredo Health Group here
News-ID: 1740441 • Views: 256
More Releases from Fact.MR
Plastic Tray Market Showcases Future Status of Prime Manufacturers Across Major …
The new report on the global plastic tray market gives estimations of the size of the international market and the overall size and share of key regional segments during the historical assessment period of 2013 - 2017. The overall outlook for the Plastic Tray Market is likely to remain sluggish, with the plastic tray market expected to reach CAGR of 3.6% in terms of revenue during 2018-2027. The business knowledge
MRI-guided Radiation Therapy Systems Market Leading Manufacturers Expected to Mo …
With a multi-disciplinary approach, Fact.MR elaborates an extensive analysis of the historical, current and future outlook of the global MRI-guided radiation therapy systems market as well as the factors responsible for such a growth. Our highly dedicated professionals have provided critical and accurate insights associated with every industry, and region by doing thorough primary and secondary research. Access Research Methodology Prepared By Experts - https://www.factmr.com/connectus/sample?flag=RM&rep_id=2572 We leverage space-age industrial and digitalization tools
Marine Seats Market Growing Demand to Impact Revenue Share during 2018 2028
The new report on the marine seats market provides estimations of the size of the global market and share and size of key regional markets during the historical period of 2013 - 2017. According to the report, the marine seats market is projected to grow at 4.6% CAGR through 2028. The business intelligence study offers readers a granular assessment of key growth dynamics, promising avenues, and the competitive landscape of
Hormone Replacement Therapy Market Displays Higher Growth Inclinations during 20 …
In a recent business intelligence study, Fact.MR presents the nitty-gritty of the global Hormone Replacement Therapy Market considering 2018-2028 as the stipulated timeframe. The business report highlights the drivers, restraints, opportunities and trends affecting market growth. Further, all the market shares associated with the market as well as the segments are expressed in terms of value and volume. Request Free Sample Report - https://www.factmr.com/connectus/sample?flag=S&rep_id=2224 Key findings of the hormone replacement therapy market
More Releases for Based
Increasing demand for biologics for various chronic diseases and rising investment in R&D for the production of biologics is expected to contribute significantly to the growth of plant-based biologics market. According to Biotechnology Innovation Organization (BIO) 2015, over 250 biologic therapies and vaccines have changed the lives of hundreds of millions of patients. Moreover, according to the same source, over 900 biologics are currently (2018) under the stage of development
Hospital-based EMR Market
Electronic medical record (EMR) is a digital version of a paper chart, which contains a patient's medical history. This system is designed to share information with other healthcare providers such as laboratories and specialists. It helps to reduce operational cost such as transcription services and overtime labor expenses. Get Sample PDF of Report@ https://www.alliedmarketresearch.com/request-toc-and-sample/3219 Increase in demand for advanced health monitoring systems drives the growth of the market. In addition, rise in
Plant Based Beverages Market
https://www.qandqmarketresearch.com/reports/7360187/plantbased-beverages-market-87 Plantbased products include plantbased beverages that are further classified into plantbased dairy alternatives, juices, and readytodrink beverages. The plantbased beverages segment is expected to witness a growing CAGR of 6.5% by 2025, owing to the changing eating habits of consumers. Consumers are more conscious about health and wellness than before, and want to consume products that are healthy and natural without compromising on the taste and flavor of the product. Increasing
Plant-based Snacks Market
https://www.qandqmarketresearch.com/reports/7287268/plantbased-snacks-market-24 Plantbased products are those products that are made entirely from plantbased ingredients, and limit or restrict any use of animalbased products. Plantbased products include plantbased snacks, which are further classified into meat alternative snacks, cereal/grainbased snacks, plantbased salted snacks, plantbased snack bars, and fruit and nut snacks. Based on regional segmentation for the plantbased snacks market, North America, Western Europe, and Asia Pacific are estimated to dominate the global plantbased
Account Based Marketing
Today, most of the marketing organizations are moving towards the Account Based Marketing ( ABM ) . The ABM approach has been there for years but the recent technologies available have made this approach scalable and hence more effective and popular. The traditional marketing approach has been around attracting your prospects from a larger pool. The account based marketing is about targeting accounts based on your best business connection. It is
Clinical Nutrition Market 2016: Infant, Milk-based, Soy-based
Latest industry research report on Clinical nutrition products are type of pharmaceutical products, which help to keep patient healthy. They aid to improve metabolic system of the body by providing adequate supplements such as minerals, vitamins and others. Rising instances of chronic and lifestyle diseases and increasing population that receives malnutrition treatment are the major factors responsible for driving the growth of the market. Furthermore, rise in global population, disposable